LGALS1 and cancer: Within melanoma, Gal-1 has a key role in therapy resistance, resisting MAPK inhibitors and chemotherapy, and cancer progression, including promoting immune evasion, SOX10-linked plasticity, and VEGF-independent angiogenesis.